F2I Partners LLC

Walk through any university incubator or startup accelerator and you’ll find it. A dozen brilliant ideas, a handful of groundbreaking discoveries, and one tragic truth: Most biotech startups fail. Not because the science is bad. They fail because the infrastructure isn’t there. --- The Innovation Trap Biotech founders often start with a bold vision. A new therapy, diagnostic, or platform that could change medicine. But somewhere between the bench and the cleanroom, innovation

Walk into any GMP facility and you’ll hear it whispered over coffee or muttered during protocol review: “Validation is broken.” We all know it, but few are willing to say it out loud. For years, validation has been treated like a bureaucratic ritual: a mountain of documents meant to prove compliance rather than performance. We generate protocols, execute tests, and issue final reports that may satisfy auditors, but do they really prove our processes are robust, reproducible,